A theranostic agent for cancer therapy and imaging in the second near-infrared window
- 169 Downloads
Theranostic nanoparticles are integrated systems useful for simultaneous diagnosis and imaging guided delivery of therapeutic drugs, with wide ranging potential applications in the clinic. Here we developed a theranostic nanoparticle (~ 24 nm size by dynamic light scattering) p-FE-PTX-FA based on polymeric micelle encapsulating an organic dye (FE) fluorescing in the 1,000–1,700 nm second near-infrared (NIR-II) window and an anti-cancer drug paclitaxel. Folic acid (FA) was conjugated to the nanoparticles to afford specific binding to molecular folate receptors on murine breast cancer 4T1 tumor cells. In vivo, the nanoparticles accumulated in 4T1 tumor through both passive and active targeting effect. Under an 808 nm laser excitation, fluorescence detection above 1,300 nm afforded a large Stokes shift, allowing targeted molecular imaging tumor with high signal to background ratios, reaching a high tumor to normal tissue signal ratio (T/NT) of (20.0 ± 2.3). Further, 4T1 tumors on mice were completed eradicated by paclitaxel released from p-FE-PTA-FA within 20 days of the first injection. Pharmacokinetics and histology studies indicated p-FE-PTX-FA had no obvious toxic side effects to major organs. This represented the first NIR-II theranostic agent developed.
Keywordstheranostic nanoparticles second near-infrared window fluorescence imaging cancer therapy
Unable to display preview. Download preview PDF.
This study was supported by National Institutes of Health NIH DP1-NS-105737, the Deng family gift, and the Shenzhen Peacock Program Grant KQTD20140630160825828.
- Liu, T.; Wu, G. Y.; Cheng, J. J.; Lu, Q.; Yao, Y. J.; Liu, Z. J.; Zhu, D. C.; Zhou, J.; Xu, J. R.; Zhu, J. et al. Multifunctional lymph-targeted platform based on Mn@mSiO2 nanocomposites: Combining PFOB for dual-mode imaging and DOX for cancer diagnose and treatment. Nano Res. 2016, 9, 473–489.CrossRefGoogle Scholar
- Hatami, S.; Würth, C.; Kaiser, M.; Leubner, S.; Gabriel, S.; Bahrig, L.; Lesnyak, V.; Pauli, J.; Gaponik, N.; Eychmüller, A. et al. Absolute photoluminescence quantum yields of IR26 and IR-emissive Cd1−x Hgx Te and PbS quantum dots—Method- and material-inherent challenges. Nanoscale 2015, 7, 133–143.CrossRefGoogle Scholar
- Karimi Shervedani, R.; Yaghoobi, F.; Torabi, M.; Samiei Foroushani, M. Nanobioconjugated system formed of folic acid–deferrioxamine–Ga(III) on gold surface: Preparation, characterization, and activities for capturing of mouse breast cancer cells 4T1. J. Phys. Chem. C 2016, 120, 23212–23220.CrossRefGoogle Scholar
- Zhu, S. J.; Yang, Q. L.; Antaris, A. L.; Yue, J. Y.; Ma, Z. R.; Wang, H. S.; Huang, W.; Wan, H.; Wang, J.; Diao, S. et al. Molecular imaging of biological systems with a clickable dye in the broad 800- to 1,700-nm near-infrared window. Proc. Natl. Acad. Sci. USA 2017, 114, 962–967.CrossRefGoogle Scholar
- Yi, X. L.; Lian, X. H.; Dong, J. X.; Wan, Z. Y.; Xia, C. Y.; Song, X.; Fu, Y.; Gong, T.; Zhang, Z. R. Co-delivery of pirarubicin and paclitaxel by human serum albumin nanoparticles to enhance antitumor effect and reduce systemic toxicity in breast cancers. Mol. Pharmaceutics 2015, 12, 4085–4098.CrossRefGoogle Scholar
- Oh, N.; Park, J. H. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomedicine 2014, 9, 51–63.Google Scholar
- Wang, D. L.; Liu, B.; Ma, Y.; Wu, C. W.; Mou, Q. B.; Deng, H. P.; Wang, R. B.; Yan, D. Y.; Zhang, C.; Zhu, X. Y. A molecular recognition approach to synthesize nucleoside analogue based multifunctional nanoparticles for targeted cancer therapy. J. Am. Chem. Soc. 2017, 139, 14021–14024.CrossRefGoogle Scholar
© Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature 2018